Preparation method of chitosan grafted polyethyleneimine non-viral transgene vector

A polyethyleneimine and transgenic carrier technology, which is applied in the field of biomedical materials, can solve the problems that the advantages of chitosan and polyethyleneimine cannot be fully utilized, and the chemical link is non-degradable, so as to improve the efficiency and conditions of gene transfection. mild, cytotoxic effect

Active Publication Date: 2013-04-10
SHENZHEN INST OF ADVANCED TECH
View PDF1 Cites 30 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Combining the biocompatibility of chitosan and the transfection efficiency of polyethyleneimine, it is expected to develop a safe and efficient transgenic carrier, but the chemical links currently used to construct copolymers are all non-degradable links, which cannot completely Give full play to the respective advantages of chitosan and polyethyleneimine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of chitosan grafted polyethyleneimine non-viral transgene vector
  • Preparation method of chitosan grafted polyethyleneimine non-viral transgene vector
  • Preparation method of chitosan grafted polyethyleneimine non-viral transgene vector

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0016] The embodiment of the present invention provides a kind of preparation method of chitosan grafted polyethylenimine non-viral transgene carrier, it comprises the steps:

[0017] S01: Obtaining thiolated polyethyleneimine and thiolated chitosan;

[0018] S02: oxidize the thiolated polyethyleneimine and thiolated chitosan to form a disulfide bond, and obtain the chitosan-grafted polyethyleneimine non-viral transgene carrier.

[0019] In step S01, both the mercaptolated polyethyleneimine and the mercaptolated chitosan can be prepared by the prior art or obtained commercially. As described, thiolated polyethyleneimine can be obtained by reacting branched amino groups with mercaptocarboxylic acids, or by first reacting with heterobifunctional cross-linking agent N-hydroxysuccinimide-3-(2-pyryl disulfide )-propionate (SPDP) reaction to obtain thiopolyethyleneimine, and then adding a reducing agent for reduction to obtain the thiolated polyethyleneimine. Since the thiolated c...

Embodiment 1

[0032] The reaction solution is PBS buffer (PBS, 1mM EDTA, 0.02% sodium azide, pH 7), 5 mg of polyethyleneimine with a molecular weight of 1800 Da was dissolved in 1 mL of PBS buffer, 2.5 mg of SPDP was first dissolved in 25 μL of DMSO, Then it was added dropwise into the solution of polyethyleneimine, stirred and reacted at room temperature for 24 hours, and dialyzed in deionized water for one day with a dialysis bag with a molecular weight cut-off of 1000Da to remove unreacted SPDP to obtain thiopolyethyleneimine. Take 10mg of chitosan with a molecular weight of 10000Da and a degree of deacetylation of 92% and dissolve it in 50mM acetic acid buffer solution, and then dissolve it in a reaction solution with a total volume of 1mL. Chitosan solution was stirred at room temperature for 24 hours, and a dialysis bag with a molecular weight cut-off of 3500 Da was dialyzed in deionized water for one day to remove unreacted SPDP to obtain thiochitosan.

[0033] Dithiothreitol was add...

Embodiment 2

[0036] The reaction solution is PBS buffer (PBS, 1mM EDTA, 0.02% sodium azide, pH 7). Take 5 mg of polyethyleneimine with a molecular weight of 1800Da and dissolve it in 1 mL of PBS buffer, stir at room temperature for 24 hours, and dialyze with a molecular weight cut-off of 1000Da. The bag was dialyzed against deionized water for one day to remove unreacted SPDP to yield thiopolyethyleneimine. Take 5 mg of chitosan with a molecular weight of 10,000 Da and a deacetylation degree of 92% and dissolve it in 50 mM acetic acid buffer solution, and then dissolve it in a reaction solution with a total volume of 1 mL. Dissolve 1.25 mg of SPDP in 25 μL of DMSO first, and then add it dropwise to In an aqueous solution of chitosan, stir and react at room temperature for 24 hours, then dialyze in deionized water for one day with a dialysis bag with a molecular weight cut-off of 3500 Da to remove unreacted SPDP to obtain thiochitosan.

[0037] Dithiothreitol was added to the aqueous soluti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to view more

Abstract

The invention provides a preparation method of a chitosan grafted polyethyleneimine non-viral transgene vector. The preparation method comprises the following steps: obtaining thiolated polyethyleneimine and thiolated chitosan; taking oxidation reaction to thiolated polyethyleneimine and thiolated chitosan to form a disulfide bond, and obtaining the chitosan grafted polyethyleneimine non-viral transgene vector. The invention further provides an application of the preparation method of the chitosan grafted polyethyleneimine non-viral transgene vector in gene transfection. The chitosan grafted polyethyleneimine non-viral transgene vector comprises the reduction sensitive disulfide bond, can quickly degrade and release DNA (deoxyribonucleic acid) in the reduction environment due to higher content of glutathione in a cell, and express excellent biocompatibility and high transfection efficiency, so that the chitosan grafted polyethyleneimine non-viral transgene vector is a low-toxicity and efficient non-viral transgene vector, and has a wide application prospect.

Description

technical field [0001] The invention belongs to the technical field of biomedical materials, and in particular relates to a preparation method of chitosan-grafted polyethyleneimine non-viral transgene carrier. Background technique [0002] Gene therapy achieves the therapeutic effect by carrying the target gene to target cells to achieve continuous expression of therapeutic proteins. The development of molecular biology and the establishment of human gene banks have promoted the clinical application of gene therapy, making it not only play an advantage in the treatment of hereditary congenital diseases and malignant tumors, but also more and more widely used in the treatment of various common diseases. treat. A large number of clinical trials have witnessed the development of its clinical treatment. However, so far, no transgenic product for humans has been approved by the FDA. The reason is that it is still difficult to realize the construction of safe and efficient transg...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C08G81/00C08B37/08C08G73/04C12N15/87
Inventor 赵晓丽吕维加潘浩波岳建辉
Owner SHENZHEN INST OF ADVANCED TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap